|
|
||||||||
1 Cincinnati Children's Hospital Medical Center, Division of Pulmonary Biology, Cincinnati, Ohio 45229-3039; and 2 School of Women's and Infants' Health, The University of Western Australia, Perth, Western Australia, 6008 Australia
Antenatal betamethasone (Beta) is
widely used in women with asymptomatic chorioamnionitis at risk for
preterm delivery, but its effects on fetal inflammation are unstudied.
Groups of ewes at 109 ± 1 days of gestation received the
following treatments: intra-amniotic (IA) saline (control), 0.5 mg/kg
intramuscular Beta, 10 mg IA endotoxin (Endo), and Beta + 2 h
later Endo (Beta + Endo). Beta suppressed Endo-induced lung
inflammation at 1 day. However, compared with Endo 5 days after
treatment, Beta + Endo lambs had increased alveolar neutrophils,
proinflammatory cytokine mRNA expression, and serum amyloid A3 (SAA3)
mRNA expression. IL-1
mRNA expression was localized to the
inflammatory cells, whereas SAA3 mRNA expression was induced in the
bronchial epithelium and the inflammatory cells. Compared with Endo,
Beta + Endo lambs had increased lung inflammation but equivalent
lung volumes 15 days after treatment. The late increase in inflammation
in the Beta + Endo animals suggests that glucocorticoids impair
the ability of the preterm lung to downregulate Endo-induced
inflammation after fetal clearance of the glucocorticoids. These
results have implications for lung inflammation and bronchopulmonary
dysplasia in preterm infants exposed to chorioamnionitis and maternal glucocorticoids.
bronchopulmonary dysplasia; acute-phase reactant; proinflammatory cytokines; endotoxin tolerance; chorioamnionitis
This article has been cited by other articles:
![]() |
O. M. Peltoniemi, M. A. Kari, O. Tammela, L. Lehtonen, R. Marttila, E. Halmesmaki, P. Jouppila, M. Hallman, and for the Repeat Antenatal Betamethasone Study Group Randomized Trial of a Single Repeat Dose of Prenatal Betamethasone Treatment in Imminent Preterm Birth Pediatrics, February 1, 2007; 119(2): 290 - 298. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. L. Dammann, N. Nassimi, W. Liu, and H. C. Nielsen ErbB receptor regulation by dexamethasone in mouse type II epithelial cells Eur. Respir. J., December 1, 2006; 28(6): 1117 - 1123. [Abstract] [Full Text] [PDF] |
||||
![]() |
S G Kallapur and A H Jobe Contribution of inflammation to lung injury and development. Arch. Dis. Child. Fetal Neonatal Ed., March 1, 2006; 91(2): F132 - F135. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Kallapur, T. J. M. Moss, M. Ikegami, R. L. Jasman, J. P. Newnham, and A. H. Jobe Recruited Inflammatory Cells Mediate Endotoxin-induced Lung Maturation in Preterm Fetal Lambs Am. J. Respir. Crit. Care Med., November 15, 2005; 172(10): 1315 - 1321. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Mulrooney, Z. Champion, T. J. M. Moss, I. Nitsos, M. Ikegami, and A. H. Jobe Surfactant and Physiologic Responses of Preterm Lambs to Continuous Positive Airway Pressure Am. J. Respir. Crit. Care Med., March 1, 2005; 171(5): 488 - 493. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ikegami, S. G. Kallapur, and A. H. Jobe Initial responses to ventilation of premature lambs exposed to intra-amniotic endotoxin 4 days before delivery Am J Physiol Lung Cell Mol Physiol, March 1, 2004; 286(3): L573 - L579. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |